Vacinas: Da Saúde Pública ao Big Business

Guimarães, Reinaldo

doi:10.1590/1413-81232021265.03062021

Cited by 3 publications

(1 citation statement)

References 9 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pesquisas apontam que o movimento antivacina vem crescendo e sendo observado com preocupação nos países da América do Norte e na Europa desde os anos 2000, mas no Brasil, apenas a partir de 2015 o sistema de saúde percebeu a crescente ameaça à saúde nacional e desde então busca contornar as consequências desse atraso (GUIMARÃES, 2021). Sato (2018) , 2018).…”

Section: Resultsunclassified

Movimento Antivacina: A Pandemia Da Década

Melendez¹,

MATTOS²,

XAVIER³

et al. 2023

Anais Do I Congresso Nacional De Saúde Da Família on-Line

View full text Add to dashboard Cite

Section: Resultsunclassified

Movimento Antivacina: A Pandemia Da Década

Melendez¹,

MATTOS²,

XAVIER³

et al. 2023

Anais Do I Congresso Nacional De Saúde Da Família on-Line

View full text Add to dashboard Cite

The priority areas and possible pathways for health cooperation in BRICS countries

Liu,

Wang,

et al. 2023

glob health res policy

View full text Add to dashboard Cite

As one of the largest alliances of middle-income countries, the BRICS, known as an acronym for five countries including “Brazil, Russia, India, China, and South Africa”, represents half of the global population. The health cooperation among BRICS countries will benefit their populations and other middle- and low-income countries. This study aims to summarize the current status of health cooperation in BRICS countries and identify opportunities to strengthen BRICS participation in global health governance. A literature review was conducted to analyze the status, progress, and challenges of BRICS' health cooperation. Content analysis was used to review the 2011–2021 annual joint declarations of the BRICS Health Ministers Meetings. The priority health areas were identified through segmental frequency analysis. Our research suggested that communicable diseases, access to medicine, and universal health coverage appeared most frequently in the content of declarations, indicating the possible top health priorities among BRICS' health collaboration. These priority areas align with the primary health challenges of each country, including the threats of double burden of diseases, as well as the need for improving health systems and access to medicines. Respective external cooperation, inter-BRICS health cooperation, and unified external cooperation are the main forms of health cooperation among BRICS countries. However, challenges such as the lack of a unified image and precise position, lack of practical impact, and weak discourse power have impeded the impact of BRICS on health governance. This study suggests that the BRICS countries should recognize their positioning, improve their unified image, and establish cooperative entities; at the same time, they should increase their practical strength, promote non-governmental cooperation, and expand the cooperation space through the “BRICS Plus” mechanism with countries with similar interests to join.

show abstract

On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation

Zhang,

Li,

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

BackgroundWith the perspicuous effect of COVID-19 on vaccine demand, academic and business interest in vaccine production in the BRICS nations (Brazil, the Russian Federation, India, China, and South Africa) has reached a crescendo. Aware of a “dark” past when the BRICS depended heavily on vaccines and pharmaceuticals from other parts of the world, academic curiosity on how the BRICS countries have leveraged vaccine self-sufficiency and become the hub of global vaccine production and supply is justifiable, especially in times of ineffable pandemics.MethodsThe articles were searched from November 2020 to December 2022. Within this period, an electronic search of 13 reputable healthcare and public databases was conducted. The initial searches from the designated databases yielded a total of 3,928 articles. Then, duplicated studies were removed through a two-step process, articles without titles and abstracts were excluded, and the remaining 898 articles that met the qualification assessment criteria were evaluated for article quality.ResultsThe main entrepreneurial innovations that have quickened the pace of vaccine self-sufficiency in the BRICS include investment in artificial intelligence (AI), Big Data Analytics, and Blockchain technologies. These help to speed up the drug delivery process by enhancing patient identification or optimizing potential drug candidates for clinical trials and production.ConclusionOver the past 20 years, the BRICS nations have achieved major strides in vaccine development, regulation, and production. The creation of the BRICS Vaccine Research and Development (R&D) Center will have a significant impact on vaccine cost and accessibility given the anticipated development of stronger research capability, production, and distribution technology, as well as stronger standardization to improve vaccine production quality in the near future. It is anticipated that the BRICS’ contributions to vaccine development will alter the global vaccination market and hasten the availability of vaccinations in developing nations. The challenge is turning these hopes into concrete plans of action and outcomes.

show abstract

Vacinas: Da Saúde Pública ao Big Business

Cited by 3 publications

References 9 publications

Movimento Antivacina: A Pandemia Da Década

Movimento Antivacina: A Pandemia Da Década

The priority areas and possible pathways for health cooperation in BRICS countries

On the momentum toward vaccine self-sufficiency in the BRICS: an integrative review of the role of pharmaceutical entrepreneurship and innovation

Contact Info

Product

Resources

About